Company intelligence / Profile preview

Px HealthCare

Ownership: Private
Development stage: Commercial

Overview

Px HealthCare has developed OWise, a clinically validated digital health platform for breast and prostate cancer patients, providing real-world patient experience insights and supporting informed decision-making. Its OWise breast cancer app is available in the UK, Netherlands, and US, and the prostate cancer app is available in the UK. The company has recently presented first-of-its-kind real-world evidence studies at major oncology conferences in partnership with AstraZeneca[1][2][5].

Therapeutic areas: Oncology
Modalities: Digital health platform
Industry: Digital Health Medical Devices

Partnerships

AstraZeneca

Beyond the preview

Go deeper on Px HealthCare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Px HealthCare.

Explore the full profile